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A Point Mutation in the Glutamate Binding Site
Blocks Desensitization of AMPA Receptors
causes an increase in glutamate concentrations at the
synapse (Trussell and Fischbach, 1989; Otis et al.,
1996a, 1996b; reviewed by Jones and Westbrook, 1996).
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Topological studies divide the single subunit protein intoFederal Republic of Germany
several domains: (1) four hydrophobic domains, M1±M4,
of which M1, M3, and M4 are thought to form transmem-
brane domains, while M2 forms a reentrant loop that
Summary lines the channel pore; (2) a short cytoplasmic C-terminal
domain; and (3) two extracellular domains composed of
Desensitization of a-amino-3-hydroxy-5-methyl-4-isox- the N terminus and the segment between M3 and M4
azole-propionate (AMPA) receptors is thought to shape (reviewed by Hughes, 1995; Wo and Oswald, 1995).
the synaptic response and act as a neuroprotective The extracellular domains share homology to bacterial
mechanism at central synapses, but the molecular periplasmic amino acid binding proteins (PBPs; Nakani-
mechanism underlying desensitization is poorly un- shi et al., 1990; O'Hara et al., 1993). The first z400 amino
derstood. We found that replacing the glutamate bind- acids are homologous to the lysine/isoleucine/valine-
ing domain S1 of GluR3 (an AMPA receptor) with S1 binding protein (LIVBP). The next z150 amino acids
of GluR6 (a kainate receptor) resulted in a fully active preceding M1 and the segment between M3 and M4
but completely nondesensitizing receptor. Smaller sub- are homologous to both the glutamine-binding protein
stitutions within S1 identified, besides two additional (QBP) and the lysine/arginine/ornithine-binding protein
modulatory regions, a single exchange, L507Y, as is (LAOBP). These two later segments, termed S1 and S2,
required and sufficient for the block of desensitization. were shown to determine agonist binding specificity of
This phenotype was specific for AMPA receptors and AMPA and kainate receptors (Stern-Bach et al., 1994).
required an aromatic residue at this position. L507 lies Site-directed mutagenesis studies further identified speci-
fic residues within these regions. Based on solved crys-between two residues (T504 and R509) that form part
tal structures of bacterial proteins, structural models forof the glutamate binding site. The physical proximity
the glutamate binding site of the ionotropic receptorsof these residues, which are involved in binding and
have been proposed (reviewed by Green et al., 1998;gating, suggests they may form part of the link be-
Paas, 1998). The function of the LIVBP-like domain istween these two events.
still unknown, although recently, it has been shown that
it controls, together with a short segment at the C termi-
nus of S1 (pre-M1), glycine-independent desensitizationIntroduction
of the NMDA receptors (Krupp et al., 1998; Villarroel et
al., 1998).L-glutamate, the major excitatory neurotransmitter in the
In AMPA receptors, desensitization is modulated bybrain, activates three distinct types of ionotropic recep-
alternative splicing and RNA editing of segments in S2.tors: N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-
The alternative spliced versions (known as ªflipº and5-methyl-4-isoxazole-propionate (AMPA), and kainate
ªflopº) differ in their time course of desensitization andreceptors (reviewed by Watkins and Evans, 1981; Col-
in their sensitivity to the desensitization blocker cyclothi-lingridge and Lester, 1989; Monaghan et al., 1989).
azide (Sommer et al., 1990; Mosbacher et al., 1994; Par-
AMPA and kainate receptors desensitize completely
tin et al., 1994), and some of the molecular determinants
and rapidly in response to glutamate, with a time con- for these differences have been elucidated (Partin et al.,
stant of z5 ms (Mayer and Westbrook, 1987; Trussell 1995, 1996). The amino acid preceding the alternative
and Fischbach, 1989; Jonas and Spruston, 1994; Trus- spliced flip and flop modules is subject to RNA editing,
sell et al., 1994). This profound desensitization, together and the edited channels possess faster recovery rates
with slow recovery, is thought to play a role in determin- from desensitization (R/G site; Lomeli et al., 1994). Re-
ing synaptic amplitudes, particularly during high fre- cently, it has also been demonstrated that residues at
quency of release; at synapses with multiple release the N terminus of S2 modulate desensitization of GluR1
sites; at elevated synaptic activity, when clearance of (Mano et al., 1996) and GluR6 receptors (Swanson et
glutamate is slowed; and during brain damage that al., 1997). The role of S1 in the desensitization of AMPA
receptors is unclear.
Although both AMPA and kainate receptors desensi-³ To whom correspondence should be addressed (e-mail: crosenm
@gwdg.de). tize upon continuous application of glutamate, specific
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kinetic parameters vary considerably. These include,
first, the extent of desensitization produced by various
agonists. For example, kainate produces apparent non-
desensitizing currents at AMPA receptors, while it elicits
completely desensitizing currents at kainate receptors.
Second, the time course for recovery from desensitiza-
tion is z50 times slower for the kainate receptors than
for the AMPA receptors. Third, they have differential
sensitivity to allosteric modulators. For example, Conca-
navalin A blocks desensitization at kainate receptors
but is much less potent at AMPA receptors, while
cyclothiazide blocks desensitization at AMPA receptors
but has no effect on kainate receptors (reviewed by
Bettler and Mulle, 1995). Based on these differences,
structural elements specific for AMPA and kainate re-
ceptor desensitization may reveal underlying mecha-
nisms of channel gating. We thus analyzed the kinetic
properties of the GluR3±GluR6 chimeras that were pre-
viously used to investigate receptor pharmacology
(Stern-Bach et al., 1994).
In the course of that study, we had identified certain
chimeras that did not desensitize at all, while all other
receptor channel properties remained intact. Following
this unusual behavior, additional mutagenesis identified
three regions in S1 of GluR3 that modified AMPA recep-
tor desensitization, with a major role for L507, a residue
contained in a structure controlling agonist binding.
Figure 1. The Role of the N-Terminal Region in AMPA-Type Gluta-Results mate Receptor Desensitization
(A±D) Responses to rapid application of 10 mM glutamate from
Replacing the Binding Domain S1 of GluR3 with the outside-out patches expressing homomeric receptors GluR3flip (A),
Corresponding S1 of GluR6 Results in a Fully GluR6R (B), R6TM1R3flip (C), and R3(R6S1)flip (D), measured at 260
mV. The subunit-type is illustrated above each trace. Black barsActive but Completely Nondesensitizing Receptor
correspond to GluR3, white bars to GluR6. The three small verticalAMPA- and kainate-type glutamate receptor channels
bars correspond to the transmembrane domains M1, M3, and M4,have characteristic desensitization and resensitization
respectively. The numbers correspond to the first amino acid, tokinetics. These were measured in HEK293 cells tran-
the beginning of M1, and to the last amino acid, respectively (A±C)
siently transfected with pcDNA3 vectors containing and to those at the S1 junction (D). The amino acid numbering starts
GluR3flip (an AMPA receptor) or GluR6 (a kainate recep- from the first methionine of the open reading frame. All responses
are averaged from 2±50 episodes. Inset in (A) shows the same re-tor) cDNA. For all kinetic measurements, we used out-
sponse on a 50-fold faster time scale. The solution exchange wasside-out patch recordings in combination with a rapid
estimated by the open tip current at the end of each experiment (assolution exchange system (Clements and Westbrook,
shown above, inset).1991; Colquhoun et al., 1992) in order to obtain solution
(E) Current±voltage relationship of R3(R6S1)flip in outside-out patchexchanges faster than the rate of desensitization mea- configuration. Voltage was ramped from 280 to 120 mV at 1 mV/
sured for these glutamate receptors. Patches were ex- ms. The trace represents an average of seven episodes in the pres-
ence of 10 mM glutamate after leak subtraction. Patch solutionsposed to 0.5±2 s pulses of saturating glutamate concen-
contained no polyamines.trations (10 mM). As shown in Figures 1A and 1B,
(F) Dose±response relationship for L-glutamate for GluR3flip (in pres-applying the agonist at a holding potential of 260 mV
ence of 100 mM cyclothiazide, white circles), R6TM1R3flip (blackevoked a rapidly evolving and strongly desensitizing
squares), and R3(R6S1)flip (black triangles), recorded in a whole-cellinward current for both GluR3 and GluR6 homomeric mode. Currents were normalized to the response at 10 mM. EC50
channels. The amount of desensitization, expressed as and hill slope values (n) were estimated by fitting the concentration±
current relationship with the equation Y 5 1/(1 1 [EC50/(Glu)]n) andthe ratio of peak to steady-state amplitude (P/S) was
were 148 mM/1.95 for GluR3flip, 155 mM/n 5 1.66 for R6TM1R3flip,46.2 6 3.9 for GluR3flip (n 5 13) and 236 6 53 for GluR6
and 107 mM/n 5 2.02 for R3(R6S1)flip, respectively. Data are from(n 5 14). For the rate of desensitization (RD, the inverse
five to nine cells each (at 260 mV). Error bar represents standardof the desensitization time constant), we measured
error. Inset shows typical responses of a cell transfected with
240 6 15.4 and 225 6 20 s21, respectively. Desensitiza- R3(R6S1)flip to a series of glutamate concentrations. The order of
tion was blocked by cyclothiazide (100 mM) and Conca- concentrations were control, 0.03, 0.1, 0.03, control, 0.2, 0.3, and
10 mM).navalin A (1 mg/ml), when added to the agonist solution
of GluR3flip or GluR6, respectively, resulting in P/S values
close to one (data not shown). The rate of recovery
from desensitization (RR) was measured in paired pulse respectively). The kinetic characteristics of GluR3flip and
GluR6 are consistent with published values and areprotocols and was z50 times faster for GluR3flip than for
GluR6 (29.9 6 7.1 s21 and 0.57 6 0.06 s21, n 5 10, comparable to native channels (Trussell et al., 1988;
Residues Involved in AMPA Receptor Desensitization
909
Sommer et al., 1990; Heckmann et al., 1996; Traynelis peak response of R6TM1R3 (n 5 13) and R3(R6S1) (n 5
and Wahl, 1997). 10), respectively. This inhibition is similar to that ob-
To identify specific protein domains modulating re- served for AMPA receptors saturated with cyclothiazide,
ceptor desensitization, responses to glutamate from after rapid removal of the drug from the external solution
chimeric GluR3±GluR6 receptors were analyzed (Stern- (Partin et al., 1993, 1994). Second, the steady-state am-
Bach et al., 1994). In contrast to both parent receptors, plitude of a desensitized AMPA receptor is in the range
one N-terminal chimera, termed R6TM1R3 (Figure 1C), of 2.5% of the peak response. Assuming similar channel
in which the entire extracellular N-terminal region of densities, the responses from the chimeric receptor
GluR3flip was substituted by the corresponding region should be quite small. However, patch responses were
of GluR6, showed complete removal of desensitization 156 6 78 pA (n 5 30), z13-fold greater than the average
(P/S 5 1.02 6 0.01, n 5 30; Figure 1C). peak responses to GluR3 and z3-fold greater than re-
Several studies have indicated that AMPA receptor sponses of GluR3 when treated with cyclothiazide.
desensitization is modulated by the ªflip/flopº region Third, a desensitized receptor state should be reflective
located in S2 (Sommer et al., 1990; Mosbacher et al., in its single channel behavior by either smaller conduc-
1994; Partin et al., 1994, 1995). Analysis of the flop ver- tance states, shorter mean open times, or longer shut
sion of chimera R6TM1R3 also showed complete re- times. On occasionally occurring patches that contained
moval of desensitization (P/S 5 1.07 6 0.04, n 5 9; data only a single chimeric channel, the channel opened to an
not shown), suggesting that the removal of desensitiza- apparent 23 pS state, with a very high open probability
tion does not require specific splice variants in the flip/ (88.3% 6 5% at 10 mM glutamate), similar to the con-
flop cassette. ductance behavior observed with GluR3 single channels
Based on the homology to bacterial proteins and func- treated with cyclothiazide (Rosenmund et al., 1998).
tional studies, the N-terminal region can be separated Finally, since S1 is exclusively located on the extracel-
in two, the LIVBP-like domain and the agonist binding lular site and is part of the ligand binding domain, muta-
domain S1. These two regions were examined sepa- genesis may influence agonist binding but not ion per-
rately by measuring the kinetic properties of chimera meation. Consistent with that, we found no obvious
R3(R6S1), in which the GluR6 substitution was limited differences in the current voltage properties between
to S1, and chimera R6KBPR3, in which it was limited to GluR3flip and the chimeras R6TM1R3 and R3(R6S1) (Fig-the LIVBP-like region. Chimera R3(R6S1) exhibited a ure 1E). Both chimeras responded to glutamate in a
fully nondesensitizing response (P/S 5 1.01 6 0.01, n 5
dose-dependent manner that was similar to that ob-
6; Figure 1D), whereas chimera R6KBPR3 resulted in a
served for GluR3flip (Figure 1F; see also Stern-Bach et al.,receptor indistinguishable from GluR3 (P/S 5 56.2 6 22,
1994). As agonist potency strongly depends on receptorRD 5 232 6 44 s21, RR 5 19.3 6 5.2 s21, n 5 6; data not desensitization (Trussell and Fischbach, 1989; Patneaushown). The LIVBP-like region was recently reported to
and Mayer, 1990; Patneau et al., 1993; Yamada andaffect glycine-independent NMDA receptor desensitiza-
Tang, 1993; Partin et al., 1994), we removed desensitiza-tion (Krupp et al., 1998; Villarroel et al., 1998). To further
tion of the native receptor GluR3flip by coapplying thetest its possible role in desensitization, we also checked
desensitization blocker cyclothiazide. Based on the lackthe kinetic properties of the reverse chimera R3KBPR6
of receptor desensitization, these measurements wereand of chimera NR1KBPR6, in which the LIVBP-like do-
carried out in whole-cell recordings that allowed moremain was taken from the NMDA receptor subunit NR1a
accurate measurements of current amplitudes. Potency(Stern-Bach et al., 1994). These two chimeras desensi-
values obtained from patches showed identical valuestized in a manner similar to GluR6 (R3KBPR6: P/S 5
and were thus pooled. Interestingly, cyclothiazide re-94.3 6 23, RD 5 341 6 45 s21, RR 5 0.24 6 0.07 s21,
duced glutamate potency from 155 mM to 398 mM forn 5 5; and NR1KBPR6: P/S 5 83.1 6 33, RD 5 411 6
R6TM1R3 (n 5 5) and from 107 mM to 199 mM for73 s21, RR 5 0.31 6 0.09 s21, n 5 4). Thus, abolishing
R3(R6S1) (n 5 6). A similar reduction in affinity wasdesensitization in GluR3 by the chimeric exchange is
observed for [3H]AMPA binding to rat brain membranesexclusively a result of replacing the agonist binding do-
when treated with cyclothiazide (Kessler et al., 1996).main S1.
Taken together, these results show that abolishingWe excluded for three reasons the possibility that the
desensitization in R6TM1R3 and R3(R6S1) does not re-observed lack of desensitization for chimeras R6TM1R3
sult in gross alteration of other receptor channel func-and R3(R6S1) could be due to some other form of kinetic
tions. It also suggests that desensitization is an activechange (for example, an increase of the desensitization
gating process independent from the process of acti-rate to an extent that would impede detection in our
vation.experiments), and thus, the receptor is being observed
in its desensitized state. First, desensitization of AMPA
Three Distinct Regions in S1 Modify Desensitizationreceptors can be blocked by cyclothiazide. Since both
Properties of GluR3 Receptorschimeras carry the ªGluR3-flipº region important for
The S1 region of GluR6 consists of 162 amino acids,cyclothiazide binding (Partin et al., 1995, 1996), any oc-
of which 79 are different from GluR3. To identify thecluded desensitization should be revealed by an in-
residue(s) responsible for regulating desensitization, wecrease of the peak response in the presence of this
constructed 12 new ªS1º chimeras, consisting of pro-drug. However, the addition of 100 mM cyclothiazide to
gressively smaller and complementary GluR6 substitu-the agonist solution (a concentration that increases peak
tions (N1±N6 and C1±C6, Figure 2). All of the functionalresponses of GluR3flip up to 3-fold, together with a com-
C-terminal chimeras altered the desensitization proper-plete block of desensitization; Partin et al., 1994) re-
sulted in a 14% 6 4% and 12% 6 3% inhibition of the ties of the GluR3 ªparent.º Chimeras C6, C5, C3, and C2
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Figure 2. Desensitization Properties of GluR3±S1 Chimeras
(Left column) Map of chimeras and point mutations. Respective S1 regions are shown in black (GluR3) and white (GluR6). The junction residues,
given by their number, are shown above each bar and correspond to the color code. GluR3±C1 residues 515±548 are shown in single letter
code. Letters in C1 mutants indicate the GluR6 amino acid exchanges and their positions.
(Middle column) Typical current responses to a 1 s application of 10 mM glutamate. Vertical scale bars were omitted for display purposes.
Peak response sizes ranged from 4±660 pA.
(Right column) P/S, RD, and RR values 6 standard error from 5±22 measurements each. Stars under the values indicate significant differences
compared with GluR3flip (*p , 0.05, **p , 0.01, ***p , 0.0001).
did not desensitize, while C1 was partially desensitizing desensitization of all of the C1a-C1d chimeras was sta-
tistically different (p , 0.05), suggesting that multiple(Figure 2). The kinetics of C1 were significantly different
from both GluR3flip (p , 0.001) and C2 (p , 0.001), sug- combinations of mutations are required to produce the
C1 phenotype.gesting that at least two sites within C2 modify desensiti-
zation. In addition to the replacements made at the C termi-
nus of S1, those made at the N terminus also modifiedThe 34 amino acid region replaced in C1 is proposed
to include one of the hinge regions connecting the two desensitization properties of GluR3flip. Chimeras N2, N3,
and N4 but not N6 exhibited significant reductions inagonist binding lobes (Stern-Bach et al., 1994; Sutcliffe
et al., 1996; Swanson et al., 1997) and was recently found both desensitization and resensitization rates (Figure 2).
Thus, residues located in the region between R417 andto be involved in glycine-independent NMDA receptor
desensitization (pre-M1; Krupp et al., 1998; Villarroel et Y474 may also be involved in desensitization. Further
studies are required to evaluate their exact role.al., 1998). We further examined the role of the 12 resi-
dues in R3(R6S1C1) that are different from GluR3 by In summary, three distinct regions in S1 modify desen-
sitization properties of GluR3 receptors. The first is situ-grouping them into four different chimeras (C1a-C1d;
Figure 2). In comparison to the C1 replacement, the ated between R417 and Y474 (a cross of N4 and N6
Residues Involved in AMPA Receptor Desensitization
911
exchanges), the second between A501 and D514 (a
cross of C2 and C1 exchanges), and the third between
F515 and E548 (C1).
A Single Exchange in Proximity to Residues that
Bind Glutamate Removes Desensitization
of GluR3 Receptors
The region substituted in the C2 chimera, excluding C1
(i.e., A501±D514), contains only three amino acids that
differ between GluR3 and GluR6. These are T504A,
L507Y, and E511K (Figure 3). A simultaneous exchange
of all three of these amino acids resulted in a barely
desensitizing receptor (Figure 3A). The replacement of
single amino acid residues within these positions reveals
that L507Y accounted entirely for the removal of desen-
sitization (Figure 3B, middle). Its effect was slightly re-
duced when combined with E511K (Figure 3B, right) but
not with T504A (Figure 3B, left). In addition to glutamate,
quisqualate (1 mM; P/S 5 1.03 6 0.06, n 5 34) or AMPA
(1 mM; P/S 5 1.05 6 0.03, n 5 24) also elucidated
nondesensitizing responses, with an identical efficacy of
opening as glutamate (glutamate/quisqualate 5 1.02 6
0.02 and glutamate/AMPA 5 0.97 6 0.03, n 5 7, respec-
tively). Desensitization was also abolished by the L507Y
mutation when introduced into the flop version of GluR3
(P/S 5 1.01 6 0.04, n 5 12; data not shown). In contrast
to the L507Y exchange, T504A, E511K, or their com-
bined exchange had no effect on the desensitization
rate (Figure 3C) nor on the resensitization properties of
GluR3flip (data not shown). Moreover, desensitization of
these three later mutants was completely blocked by
cyclothiazide (100 mM). In contrast, cyclothiazide re-
duced peak response of L507Y by 9.6% 6 2.7% and
reduced the affinity for glutamate from 48 to 262 mM (n 5
6), similar to what was observed for the nondesensitizing
chimeras R6TM1R3 and R3(R6S1).
Interestingly, we found that all mutants containing the
T504A exchange evoked a weak response to 10 mM
glutamateÐusually a saturating concentration (GluR3flip
receptors; Figure 1F). Responses evoked by quisqualate
(1 mM) applied to the same patch were usually about
3-fold greater than the response evoked by 10 mM gluta-
mate (see Figure 3D). The difference between glutamateFigure 3. Mutations of T504A, L507Y, and E511K on GluR3flip Differ-
entially Control Desensitization and Agonist Binding and quisqualate was observed on both desensitizing
and nondesensitizing receptors. Since T504 is proposedGluR6 residues that replace GluR3 residues are indicated by a one
letter code above each trace. to directly interact with glutamate (Stern-Bach et al.,
(A) A response from a patch containing receptors with the triple point 1994; Paas et al., 1996; Laube et al., 1997) and resides
mutations T504A, L507Y, and E511K. Specific values obtained from near R509, a residue shown by mutagenesis to be critical
13 measurements were P/S 5 1.51 6 0.07 and RD 5 50.3 6 8 s21. for agonist binding (Uchino et al., 1992), we tested(B) Representative responses from receptors containing the L507Y
whether a change in glutamate efficacy or affinity hadmutation alone (middle, P/S 5 1.01 6 0.01, n 5 12) or in combination
occurred. Dose±response analysis revealed that all mu-with T504A (left, P/S 5 1.09 6 0.04, n 5 8) or E511K (right, P/S 5
2.1 6 0.14; RD 5 8.6 6 0.45 s21; n 5 21). tants containing the T504A substitution exhibited a less
(C) Representative responses from receptors mutated in T504A (left, than 50-fold increase in the EC50 for glutamate (Figure
P/S 5 26.0 6 5.1; RD 5 90.3 6 7 s21; n 5 11), E511K (right, P/S 5 3E). The responses at saturating concentrations equaled
43.3 6 8; RD 5 90.3 6 7 s21; n 5 11), or combined (middle, P/S 5
30.7 6 7.2; RD 5 186 6 43 s21; n 5 9). All receptors were activated by
10 mM glutamate, except for those containing the T504A mutation,
where a concentration 90 mM has been used.
(D) Superimposed responses from a patch containing R3(T504A) to measured as described in Figure 1F; desensitizing receptors were
1 mM quisqualate and 10 mM and 90 mM glutamate as indicated. measured in the presence of 100 mM cyclothiazide. EC50 and hill
L-quisqualate- (1 mM) induced desensitization was similar to desen- slope values (n) were L507Y (-Y-) 5 48 mM/n 5 1.66, L507Y 1 E511K
sitization evoked by glutamate (P/S 5 24.0 6 7.1, RD 5 360 6 68 (-YK) 5 131 mM/n 5 1.52, E511K (ÐK) 5 236 mM/n 5 1.64, T504A 1
s21, n 5 8). L507Y (AY-) 5 2.09 mM/n 5 1.64, T504A 1 L507Y 1 E511K (AYK) 5
(E) Dose±Response relationships to glutamate of the mutants shown 9.6 mM/n 5 1.48, T504A (AÐ) 5 19.9 mM/n 5 1.81, and T504A 1
in (A) through (C) (indicated by letter code on each trace) were E511K (A-K) 5 21.2 mM/n 5 1.81.
Neuron
912
Y521 to glycine (n 5 7), valine (n 5 4), and glutamate
(n 5 4) resulted in desensitization properties indistin-
guishable from GluR6 wild-type (data not shown). There-
fore, this particular site (R3±507/R6±521) appears to be
specific for AMPA but not kainate receptor desensiti-
zation.
The N1 replacement (Figure 2), which includes the
L507Y mutation, resulted in a partially desensitizing re-
ceptor, similar to that found in the double mutation
L507Y 1 E511K, compared with L507Y alone (Figure
3B, right versus middle). Thus, the control of desensitiza-
tion by position 507 either may be modulated by other
residues, or position 507 is necessary but not specific
for the control of desensitization. To test this, we first
measured the effect of a reversed Y-to-L mutation on
the nondesensitizing R6TM1R3 chimera (see Figure 1C).
The resulting R6TM1R3(Y521L) receptor gained back
almost complete desensitization but with a 16-fold
slower rate (RD 5 15.4 6 1.1 s21; P/S 5 11.5 6 2.1, n 5
8; Figure 4C). Desensitization was blocked by cyclothia-
zide (Figure 4D), and resensitization was not different
compared with GluR3flip (RR 5 14.2 6 4.2 s21, n 5 3),
suggesting that the kinetic characteristics of mutant
R6TM1R3(Y521L) resemble those of GluR3.
Figure 4. Specificity of L507 for AMPA Receptor Desensitization Next, we further examined the role of position E511.
(A±D) A typical response to application of 10 mM glutamate, at 260 Recent molecular modeling of the glutamate binding
mV, obtained from a patch containing the mutants GluR1(L497Y)flip domain predicts that the region T506±V512 is a-helical
(A), GluR6(Y521L) (B), and R6TM1R3(Y521L) (C). In (D), glutamate
(see Figure 7). Both L507 and E511 are situated on theevoked current in the presence of 100 mM cyclothiazide from the
surface of lobe 1, with about the same orientation. Thesame patch as in (C).
interaction observed between these two sites could thus
be explained by either specific interactions between
the response amplitude of quisqualate (Figure 3D), indi- positions 511 and 507 or by the entire a helix nonspecifi-
cating that the efficacy of channel opening was not af- cally controlling desensitization. We therefore tested
fected by the mutation T504A. whether a tyrosine residue at position 511 will also re-
The effects on glutamate potency of both positions sult in a nondesensitizing receptor. However, mutant
T504A and L507Y were independent of each other, as R3(E511Y) exhibits desensitization properties charac-
the introduction of the T504A mutation led to a parallel teristic of the wild-type receptor (P/S 5 43.9 6 13; RD 5
reduction of potency (Y . AY 5 44-fold; YK . AYK 5 383 6 50 s21; RR 5 27.9 6 8.0 s21, n 5 4; data not
73-fold; K . AK 5 90-fold; Figure 3E), suggesting that shown). Taken together, we can conclude that L507 is
the mechanisms of the affinity shift were independent. specifically required for AMPA-type receptor desensiti-
In summary, the mutations in the region T504±E511 re- zation to occur but with an additional modulatory effect
veal an intriguing convergence of agonist binding and of surrounding residues on this position.
receptor desensitization.
Specificity of Position L507 to AMPA Removal of Desensitization Requires the Exchange
of L507 to an Aromatic ResidueReceptor Desensitization
The AMPA receptor subunits GluR1±GluR4 share high To understand the nature of the removal of desensitiza-
tion by the L507Y mutation, we introduced residuessequence homology in the S1 region (.85%), sug-
gesting that a leucine-to-tyrosine exchange on other other than tyrosine in this position (Figure 5). Of the 11
mutations tested, desensitization was blocked by threeAMPA receptor subunits as well as in native AMPA re-
ceptors would lead to the same phenotype. We tested changes, to phenylalanine (F; P/S 5 1.08 6 0.11, n 5
7; Figures 5A and 5D), tryptophan (W; P/S 5 1.01 6this by mutating position L497Y on GluR1flip, the subunit
that shares the least homology with GluR3flip. This mutant 0.03, n 5 5; Figure 5D), and histidine (H; P/S 5 2.03 6 0.4,
n 5 6; Figure 5D), all aromatic. The partial desensitizationalso resulted in a complete block of desensitization (Fig-
ure 4A). observed for mutation L507H may be due to the slightly
smaller size of the imidazole ring rather than its proton-To further test the specificity of site L507, we per-
formed a reverse mutation on the kainate receptor ation state, since we observed similar behavior at differ-
ent pH values (data not shown). Exchanges to the ali-GluR6. Mutant R6(Y521L) was almost identical in its ki-
netics when compared with the wild-type GluR6 recep- phatic alcohol side chains serine (S; Figure 5B) and
threonine (T; Figure 5C) resulted in fully desensitizingtor (Figure 4B). This result implies that Y521 is not in-
volved in kainate receptor desensitization, although it receptors, with a significant faster desensitization rate,
RD, for the L507T. A similar increase was also observedwas possible that a change to something other than
leucine might have an effect. However, mutations of by the mutation to asparagine (N; Figure 5D). Finally,
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Figure 6. Kainate Elicits Fast Desensitizing Responses at AMPA
Receptors
(A) Plot correlates the efficacy of kainate currents (expressed as the
ratio of peak kainate current to peak glutamate current) to the P/S
of glutamate currents from all receptors examined in Figures 1 and
2 (represented as black circles). Correlation coefficient was 0.91.
(B) A typical response to application of 5 mM kainate, at 260 mV,
obtained from the 16-fold slower desensitizing chimera R6TM1R3
(Y521L). Data are from the same patch as shown in Figures 4C±4D.
Insert exemplifies kainate current desensitization.
glutamate-induced desensitization (Figure 6A). The fully
desensitizing receptors exhibited a peak glutamate/kai-
nate response ratio (G/K) of 53.2 6 5.3 (n 5 55), whileFigure 5. Aromatic Residues in Position 507 Remove Desensiti-
for all nondesensitizing mutants, G/K was 6.21 6 0.7zation
(n 5 66). The lack of apparent receptor desensitization,(A±C) A typical response to application of 10 mM glutamate, at
in contrast to native AMPA receptors (Patneau et al.,260mV, obtained from a patch containing the GluR3flip mutants
L507F (A), L507S (B), and L507T (C). Inset in (C) shows the same 1993), may result from desensitization kinetics that are
trace on a faster time scale. The time constant of desensitization is considerably faster than those of activation, thus being
0.72 ms. either not measurable or overlooked. To test this idea,
(D) RD for various substitutions at 507, indicated by a one letter code we took advantage of the 16-fold slower desensitizingfor the respective amino acids. Significant deviations from the native
receptor R6TM1R3(Y521L). Desensitizing responses toreceptor R3(L507), left, are indicated with an asterisk.
kainate were now apparent (P/S 5 2.71 6 0.2; RD 5
155 6 28 s21; n 5 6; Figure 6B). Similar results were
obtained from chimeras N1±N3 (n 5 21; Figure 2 andexchanges to the basic/positively charged lysine (K),
data not shown), indicating the validity of this aforemen-acidic/negatively charged glutamate (E), or to the rela-
tioned hypothesis. As kainate responses evoked ontively small side chains valine (V) and glycine (G) had no
AMPA receptors appear rapidly desensitizing and re-apparent effect on desensitization when compared with
spond comparably as well as glutamate to the removalGluR3flip (Figure 5D).
of desensitization by the S1 chimeras, the conforma-
tions the receptor undergoes upon agonist binding oc-
Kainate Elicits Fast Desensitizing Currents curs regardless of which agonist is used. Differences in
at AMPA Receptors respect to the agonist may be the speed of the desensiti-
A structural tie between agonist binding and desensiti- zation process, however.
zation could be the basis for the observation that AMPA
receptor desensitization depends on the agonist used.
Kainate applied to AMPA receptors induces rapid, much Discussion
weaker desensitizing responses, with considerably lower
agonist efficacy than AMPA or glutamate (Patneau and The process of glutamate receptor desensitization is
thought to be coupled to binding of the agonist. How-Mayer, 1991; Patneau et al., 1993). If kainate binding and
activation induce conformational changes other than ever, little is known about the structures and mecha-
nisms underlying the gating process. By following thethose induced by glutamate (particularly the one associ-
ated with desensitization), the degree of glutamate- abnormal nondesensitizing behavior of a chimeric GluR3±
GluR6 receptor, we were able to detect a single muta-induced desensitization expressed by a receptor should
not influence its kainate response. Responses evoked tion, L507Y, that abolished GluR3 receptor desensiti-
zation. L507 resides in between two residues that areby saturating kainate concentrations (5±10 mM) from
the GluR3±S1 chimeras (see Figures 1 and 2) were all involved in glutamate binding, T504 and R509. More-
over, an identical mutation made on GluR1, anotheressentially nondesensitizing. The efficacy of kainate was
maximal for nondesensitizing receptors and was posi- AMPA receptor subunit, also resulted in a nondesensi-
tizing receptor. In contrast, the corresponding reversetively correlated (r 5 0.91) to the degree of inhibition of
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mutation, Y521L, made on the kainate receptor GluR6, al., 1993). Our results further support this observation.
In general, responses to kainate from chimeras that werehad only a marginal effect on receptor desensitization.
Two conclusions can be drawn based on these re- nondesensitizing had a higher efficacy compared with
responses evoked by desensitizing receptors, suggest-sults. First, our data directly link the conformational
change induced by the binding of the agonist to both ing that kainate efficacy is correlated with the degree
of receptor desensitization. The maximal efficacy of kai-activation and desensitization, since we observed three
intertwined residues on one secondary structure ele- nate we observed was in the range of 25%, however.
Furthermore, using the 16-fold slower but fully desensi-ment that independently control agonist binding and
desensitization. Following binding, activation and de- tizing chimera R6TM1R3(Y521L), kainate-induced de-
sensitization became more apparent (Figure 6B). Thus,sensitization then proceed in two independent and sep-
arable conformational changes. Second, the relatively it is likely that the differences in desensitization rates
observed for kainate versus glutamate are based on theclean separation of desensitization without or only mildly
affecting binding or activation suggests that activation, ability of kainate-activated AMPA receptors to make the
desensitization process more rapid, and thus, to makebut not desensitization, is a conserved process within
the glutamate receptor family. Since site L507 was found it hard to detect. This may suggest that the first step
required for the desensitized state occurs as fast asto be required for AMPA but not kainate receptor desen-
sitization, AMPA and kainate receptors probably have binding and possibly faster than activation.
unique structural motifs that shape their desensitization
properties.
Structural Elements Unique for AMPA
Receptor Desensitization
Both GluR6 and GluR3 receptors desensitize rapidly andTechnical Limitations of Mapping Structures
to Measurements of Desensitization almost completely in response to glutamate. The con-
servative mutational analysis we have employed screensTwo main problems arise in studying the molecular
events underlying AMPA receptor channel desensitiza- for structural motifs that are unique for both receptors.
This was shown most dramatically with the identifica-tion. A mutational approach generates uncertainty over
how mutations to single residues or segments affect the tion of position L507. Contrary to the corresponding
position 521 in GluR6 receptors, L507 was required andstructure of the receptor in general. However, we believe
this is a minor problem in our study. Chimeric exchanges sufficient to control AMPA receptor desensitization. The
specific phenotypes observed with the L507 mutationsbetween AMPA and kainate receptors represent conser-
vative mutations, as both receptors share high sequence and the rescue of AMPA-like desensitization with chi-
mera R6TM1R3(Y521L) indicate a major role of this resi-homology. We observed no drastic changes whether
only the residue L507 or the entire N-terminal part of due in the process of AMPA but not kainate receptor
desensitization. In support of this, L507 is conserved forthe protein has been exchanged with GluR6 residues.
In addition, the apparent nondesensitizing behavior did all AMPA receptors, while in kainate receptors, GluR5/6
contains a tyrosine in the corresponding position 521not alter other receptor channel properties. On the other
hand, a major limitation of the ªchimericº approach is and GluR7 contains a histidine. This hypothesis that
AMPA and kainate receptors exhibit unique structuralthat structures controlling desensitization that are com-
mon to both receptors will not be detected. For example, elements awaits proof, however. Data obtained using a
complementary approach to kainate receptor desensiti-the modest effect (compared with L507Y) observed by
the replacements made N- and C- terminal to L507 (i.e., zation may provide an answer.
Another region, R417±Y474 (as defined by the chime-N2, N3, N4, and C1; Figure 2) may be due to highly
conservative changes, and thus specific residues in ras N2±N4 versus N6; Figure 2), seems to contain struc-
tures unique for the extremely slow recovery from de-these positions may have a more important role in de-
sensitization than we observed. sensitization of kainate receptors, as the introduction
of this segment in AMPA receptors significantly slowedAnother problem arises from the methods we used to
detect desensitization. An accurate measurement re- resensitization rates (Figure 2). The underlying mecha-
nism requires more detailed examination. Moreover, thequires that channel activation occur much faster than
the rate of desensitization. Although a fast flow system exchange of this region also significantly reduced the
rate of desensitization. As with the region surroundingwith solution exchange times of 300 ms and high agonist
concentrations were used, one cannot exclude that the L507, it contains residues that line the agonist binding
pocket (e.g., T423±S427 and D471±Y474), further sup-rate of desensitization exceeds activation. However, in
all cases where single channels from nondesensitizing porting the close molecular tie between agonist binding
and desensitization. Additional mutagenesis is requiredreceptors could be observed (n 5 34), the same large
conductance sizes (23 pS) and high open probability to identify the specific sites involved.
Previous mutational studies indicated other regions(z90%) at high agonist concentrations were seen.
Therefore, gating modes carrying larger currents, as has that are involved in AMPA/kainate receptor desensitiza-
tion. Mutations of residue S650 at the N terminus of S2been observed for the steady-state response of the non-
desensitizing receptors, are unlikely. in GluR1 (Mano et al., 1996) and the corresponding site
A689 of GluR6 (Swanson et al., 1997) have been shownThe problem of detection is more apparent for the
interpretation of kainate-induced currents. It was pre- to change desensitization properties. However, a similar
mutation (S680A) made on GluR3 or on the nondesensi-viously shown that kainate can evoke very rapidly de-
sensitizing responses at AMPA receptors (Patneau et tizing R3(L507Y) had no effect on their kinetic properties
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(P/S 5 49.9 6 17, n 5 5 and P/S 5 1.05 6 0.02, n 5
5, respectively). Another study on the mechanism of
cyclothiazide, an allosteric modulator that blocks AMPA
but not kainate receptor desensitization, suggests some
common form of desensitization. A serine residue in
position S780 (S750 in GluR1flip), part of the flip/flop mod-
ule (see Figure 7), is required for the block of desensitiza-
tion by cyclothiazide (Partin et al., 1995). It was further
shown that the introduction of serine in the correspond-
ing position of GluR6 enabled modulation by cyclothi-
azide.
NMDA receptors also desensitize upon application
of glutamate, although on a different time scale and
involving multiple mechanisms. Using homologous ex-
changes between the desensitizing NR2A subunit and
the nondesensitizing NR2C subunit, it has been recently
found that glycine-independent desensitization of NMDA
receptors is controlled by two distinct domains, one
adjacent and preceding the binding domain S1 (the
LIVBP-like region, pre-S1) and another immediately pre-
ceding M1 (pre-M1; Krupp et al., 1998; Villarroel et al.,
1998). A role for the pre-S1 region in AMPA receptor
desensitization was not apparent in our study. The com-
plementary exchanges of this region between GluR3
and GluR6, or even with the NMDA receptor subunit Figure 7. A Model for the GluR3 S1±S2 Binding Domains Based on
NR1, did not alter the desensitization properties of the the Resolved ªClosedº Structure of LAOBP
parent receptor. As discussed above, the limitation of This image was generated as described in Stern-Bach et al. (1994).
our mutagenesis approach does not rule out the partici- S1 and S2 are colored blue and gold, respectively, except for the
flip/flop region in S2, which is colored red. The side chains of T504,pation of residues N-terminal to S1 in AMPA receptor
L507, R509, E511, and N780 are marked. The orientation of thedesensitization. It is interesting to note that two other
structure with respect to the membrane is unknown. The orientationregions in NR2A, termed N6 and module 5 (Villarroel et
of L507 is similar when modeled according to QBP (T. Green, per-
al., 1998), were also found to modulate NMDA receptor sonal communication).
desensitization. Segment N6 contains the site corre-
sponding to L507 in GluR3, and module 5 is located at
activation, while additional interaction with lobe 2 causes
the N terminus of S2.
channel desensitization. However, L507 is part of a short
The modulation we observed in the C1 region of GluR3
a helix within lobe 1 (Figure 7), positioned on the surface
(pre-M1 of NMDA receptors) is complex and involves and close and opposite to the residues involved in ago-
multiple substitutions (Figure 2). Significant changes in nist binding (T504 and T509), arguing strongly that ago-
the P/S ratio rather than the desensitization rate were nist binding initiates the desensitization process within
observed. However, in contrast to the NMDA receptors, lobe 1.
the replacement of small subsets of residues was not The movement of L507 during binding (perhaps to-
sufficient in modulating desensitization. Together with gether with structures within R417±Y474) may therefore
the z10-fold difference in desensitization rates, propos- be the first in the cascade of conformational changes
ing a common mechanism for pre-M1 and C1-like de- leading to desensitization. The subsequent changes
sensitization would be premature. Resolution of the may be within the subunit monomer and/or involve
three-dimensional structure awaits to clarify the situ- neighboring subunits forming the oligomeric receptor
ation. channel complex. Such interactions could be confined
to lobe 1, between lobes 1 and 2, or between lobe 1 and
another unknown structure. Currently, most elements
The Role of L507 in AMPA Receptor Desensitization found to affect desensitization are contained within lobe
Based on homology to the bacterial PBPs and subse- 1. The N-terminal region of S1 (R417±Y474) modulated
quent experimental data, current structural models sug- de- and resensitization rates, and the C1 segment tra-
gest that the glutamate binding domain is formed by versing toward lobe 2 and the membrane affected the
two lobes that bind the agonist molecule between them extent of desensitization. The flip/flop module, connect-
(Stern-Bach et al., 1994; Paas et al., 1996; Sutcliffe et ing lobe 1 to the membrane, regulates recovery, desensi-
al., 1996; Swanson et al., 1997). S1 and the C-terminal tization rates, and modulation by the desensitization
half of S2 form the larger lobe 1, while the N-terminal blocker cyclothiazide.
half of S2 forms the smaller lobe 2 (see Figure 7). Ac- As L507 is proposed to be on the surface of lobe 1
cording to the proposed ªVenus flytrapº model (Mano pointing away from the center, the current structural
et al., 1996), the agonist binds first to lobe 1, establishing models cannot predict the segment(s) that interacts with
an ªopen-boundº configuration, and then interacts with L507. The observation that the reverse mutation Y-to-L
lobe 2, forming the ªclosed-boundº configuration. The on the nondesensitizing chimera R6TM1R3 restored de-
sensitization almost completely suggests that L507 hasopen-bound form has been proposed to induce channel
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to interact with residues C-terminal to it, assuming a by our mutations (Rosenmund et al., 1998 and unpub-
lished data), we favor a model in which the mutationsyet unproven intrasubunit interaction. Candidate amino
acids may be those found at the N terminus of S2 forming at site L507 prevent entry into the desensitized state.
Taking into account the z3-fold reduction in gluta-lobe 2 or in the flip/flop region contained in lobe 1.
However, none of these structures seems to interact mate affinity by cyclothiazide, as observed for the non-
desensitizing mutants and in binding studies (Kesslerdirectly, based on predicted long distances to L507 (see
Figure 7). et al., 1996), the actual EC50 value for wild-type GluR3flip
(compared with the measured 148 mM) could be veryTwo other possibilities exist. First, one could specu-
late that L507 (alone or in concert with other residues) similar to that obtained for the point mutant R3(L507Y)
(48 mM). In this respect, the effect of removal of desensi-interacts directly with the conduction pathway, as the
orientation of the lobes relative to the membrane is not tization by the drug at the glutamatergic synapse may
be underestimated. Besides a reported action of cyclo-yet defined. An analogy may be found in the a7 nicotinic
receptor, where a leucine ring in the transmembrane thiazide on release (Diamond and Jahr, 1995), an in-
creased efficacy of opening based on the removal ofdomain is thought to control agonist-dependent desen-
sitization (Labarca et al., 1995). Alternatively, L507 may desensitization could be offset by a reduction of recep-
tor affinity, particularly in synapses that show a lowinteract with L507 (or another residue(s) located on
neighboring subunits, as they may have close contact degree of postsynaptic receptor saturation.
at this position. An aromatic bulky residue at this posi-
tion may destabilize the oligomeric interaction and thus Concluding Remarks
hinder conformational processes underlying desensiti- Following abnormal behavior of chimeric AMPA/kainate
zation. This is supported by the orientation of residue receptors, we were able to identify critical residues for
S780 (S750 in GluR1flip), found to be critical for cyclothia- AMPA receptor desensitization. Our results also provide
zide binding. S780 is facing the same direction as L507 a strong molecular basis for the hypothesis that receptor
(Figure 7), and it was proposed that cyclothiazide might desensitization is directly linked to agonist binding.
bind between subunits to accomplish its action on de- Applying a similar mutagenesis approach on GluR6 may
sensitization (Partin et al., 1995). further extend our knowledge of the mechanisms of
glutamate receptor desensitization.
Glutamate receptor stripped of desensitization may
Desensitization, Open Probability, serve as a biosensor for glutamate concentrations (snif-
and Agonist Affinity fer patch) in screening for neuroprotective and nootropic
Our present results, together with our recent discovery drugs, and it provides a powerful tool for investigating
that single channel conductance is controlled by the receptor channel properties masked so far by the fast
number of activated subunits (Rosenmund et al., 1998), onset of receptor desensitization. For example, by
indirectly suggest that desensitization controls the effi- studying the single channel properties of the nondesen-
cacy of channel opening and dissociation kinetics. As sitizing chimera R6TM1R3, we were able to detect three
full conductance is reached by the concerted activation conductance states that depend on the number of ago-
of four subunits, activation kinetics (that are agonist nists bound, a finding that led us to propose that gluta-
concentration±dependent) compete with the ongoing mate receptors are tetramers (Rosenmund et al., 1998).
desensitization kinetics, with the result that a higher
concentration of agonists are needed to reach the maxi-
Experimental Procedures
mum current. In experiments done with single channels
of the nondesensitizing receptor R6TM1R3 (Rosenmund Construction of Chimeras and Mutants
et al., 1998), following removal of the agonist, we ob- Chimeras N1±N6 and C1±C6 were made as previously described
(Stern-Bach et al., 1994). Point mutations were synthesized by theserved latencies for the switch from the large, fully occu-
PCR-based method described by the QuickChange mutagenesispied conductance state to smaller conductances that
(Stratagene). All mutants were first subcloned by an appropriatewere longer than predicted (C. R., unpublished data).
digest in GluR3flip-pGEMHE and subsequently moved into pCDNA3We interpret these slowed ªdissociation kineticsº as (InVitrogen) for expression in mammalian cells. All mutations were
trappings of the agonist, owing to the high open proba- verified by double strand DNA sequencing. The original flop module
bility of the large conductance state (assuming that dis- of chimeras R6TM1R3 and R3(R6S1) (Stern-Bach et al., 1994) has
been replaced with the corresponding flip module by using a SalI/sociation is not possible in the open channel state). This
XbaI digest of GluR3flip. Amino acid numbering starts from the firstmay explain the observed apparent increase in agonist
methionine of the open reading frame.affinity either by mutation of site 507 or by coapplication
of cyclothiazide as well as the slowed current deactiva-
Electrophysiologytion upon removal of desensitization (Patneau et al.,
Outside-out patches were obtained from the human embryonic cell
1993; Yamada and Tang 1993; Partin et al., 1994). In the line HEK293 (ATCC), expressing homomeric channels composed of
a7 nicotinic receptors, mutations that reduce desensiti- rat GluR3flip, GluR6R, or chimeras 12±96 hr after transfection by the
Ca2(PO4)3-method (Chen and Okayama, 1988). Transfected cellszation also result in an apparent increased affinity for
were detected as described (Margolskee et al., 1993). All kineticagonists (Revah et al, 1991; Bertrand et al., 1992). Since
measurements were obtained from outside-out patches to maximizean 80 pS state was observed in addition to the original
solution exchange rates. After excision of the patch, the patch was45 pS, the apparent increase in affinity has been ex-
moved into a stream of a rapid perfusion system (Clements and
plained by making the desensitized state permeable by Westbrook, 1991; Colquhoun et al., 1992). Solution exchange (20%±
these mutations (Bertrand et al., 1992). However, since 80% to peak) was judged by open tip control by diluting the control
solution with 2% water ranging from 0.3±0.6 ms. Experiments werewe did not observe any additional conductance state(s)
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performed at room temperature (208C±258C). Repeated agonist ap- Jonas, P., and Spruston, N. (1994). Mechanisms shaping glutamate-
mediated excitatory postsynaptic currents in the CNS. Curr. Opin.plication was done at 0.2±0.02 Hz. Recovery from desensitization
Neurobiol. 4, 366±372.was measured by paired pulse application of the agonist. Pipettes
were filled with a solution containing 150 mM CsF or CsCl, 20 mM Jones, M.V., and Westbrook, G.L. (1996). The impact of receptor
HEPES, 10 mM NaCl, and 10 mM EGTA, adjusted to 305 mOsm (pH desensitization on fast synaptic transmission. Trends Neurosci. 19,
7.3). Holding potential was usually 260 mV. Currents were amplified 96±101.
with an Axopatch amplifier 200 B (Axon Instruments), filtered at Kessler, M., Arai, A., Quan, A., and Lynch, G. (1996). Effect of cyclo-
1±10 kHz, and digitized at 2±20 kHz with the pClamp 6.0 (Axon thiazide on binding properties of AMPA-type glutamate receptors:
Instruments) acquisition system. The extracellular medium con- lack of competition between cyclothiazide and GYKI 52466. Mol.
tained 170 mM NaCl, 10 mM HEPES, 2±4 mM CaCl2, and 2±4 mM Pharmacol. 49, 123±131.
MgCl2, adjusted to 330 mOsm (pH 7.25). Agonist solutions were Krupp, J.J., Vissel, B., Heinemann, S.F., and Westbrook, G.L. (1998).
made by mixing external medium with isotonic (330 mOsm [pH 7.3]) N-terminal domains in the NR2 subunit control desensitization of
agonist stock solutions by replacing NaCl with the agonist. Analysis NMDA receptors. Neuron 20, 317±327.
was performed with Axograph 3.5 software, and exponentials were
Labarca, C., Nowak, M.W., Zhang, H., Tang, L., Deshpande, P.,fitted by the squared error method. Multiple measurements from
and Lester, H.A. (1995). Channel gating governed symmetrically byone patch were averaged, and the results were treated as one exper-
conserved leucine residues in the M2 domain of nicotinic receptors.iment. The significance of results was determined by analysis of
Nature 376, 514±516.
variance followed by Dunns posthoc comparison and are indicated
Laube, B., Hirai, H., Sturgess, M., Betz, H., and Kuhse, J. (1997).when p , 0.05.
Molecular determinants of agonist discrimination by NMDA receptor
subunits: analysis of the glutamate binding site on the NR2B subunit.
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